The online format allowed me to continue my work in Japan. As the UK is a leading country in public health research, I knew that the programme would provide the latest information as well as basic concepts.What were the highlights and challenges from your time as an online MPH student?
The highlight was definitely the dissertation, where I was required to apply the things I learned. As for challenges, the main ones were writing in English and managing my time. Being several time zones ahead of other students, I had to get up early to read and reply to the comments they had posted in the online classroom during the night (daytime for them). Then I worked during the day, did the housework and studied at night.Who did you meet in the virtual classroom?
My fellow students were from around the world, including Nigeria, Austria, UK, Canada, and south Asian countries. They came from a variety of professional backgrounds – for example, medical doctor, nurse, pharmacist and researcher.How is your MPH study helping you to make a difference in your career and community?
The MPH study has given me a wider view and deepened my knowledge of how pharmaceutical science connects with the public and society. Issues in public health are so complex and broad. They vary from country to country, and even from community to community.
My dissertation research into polypharmcy, or multiple drug usage, among the elderly (see below) is very relevant for my work in Japan where we have a rapidly ageing society.I would recommend the University of Liverpool because…
the University provides an opportunity to experience cultural diversity by interacting with students from all over the world.Research...
For her University of Liverpool MPH dissertation, Kaori researched drug utilisation among a cohort of elderly patients in Hiroshima, Japan. The objective was to describe drug use patterns and to identify risk patterns for polypharmacy (multiple drug use) in the cohort.
“The research showed that age was not an independent predictor of polypharmancy among elderly people in this sample, unlike other studies,” said Kaori. “The results of this analysis suggest that prevention strategies for adverse drug events (ADEs) resulting from polypharmacy should target those patients who are more sick, based on comorbidities”.
Kaori’s ongoing research focus is chronic disease and medication usage in Japan. View the research Kaori presented at the International Society of Pharmacoepidemiology.